Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Orgovyx (relugolix)
i
Other names:
RVT-601, TAK 385 , TAK-385, RVT 601, MVT-601, T-1331285
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
ASKA Pharma, Gedeon Richter, Intas, Pfizer, Sumitomo Pharma, Takeda
Drug class:
GnRH antagonist
Related drugs:
‹
degarelix (3)
cetrorelix (0)
abarelix (0)
SHR7280 (0)
VERU-100 (0)
linzagolix (0)
ARD-03 (0)
degarelix (3)
cetrorelix (0)
abarelix (0)
SHR7280 (0)
VERU-100 (0)
linzagolix (0)
ARD-03 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
relugolix
Sensitive: A1 - Approval
relugolix
Sensitive
:
A1
relugolix
Sensitive: A1 - Approval
relugolix
Sensitive
:
A1
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login